Back to discover
Drug
Acetosulfame
Research stageEmerging research
Also known as Acesulfamo, ACESULFAME.
1
Research papers
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this drug.
Long-term metabolic effects of non-nutritive sweeteners.
Research2024-07-06Molecular metabolism
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Canonical name
Acetosulfame
Aliases & brands
AcesulfamoACESULFAME
RxNorm CUI
1310546
ChEMBL ID
CHEMBL176687
UNII
MA3UYZ6K1H
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Most influential
Major research themes2
Diet, High-Fat1Non-Nutritive Sweeteners1
Journals, researchers & institutions
Top journals
- Molecular metabolism1
Leading researchers
- Amir A1
- Azem L1
- Braun T1
- Efroni G1
- Haberman Y1
- Hadar R1
- Livne R1
- Rathaus M1
Leading institutions
free-text, unnormalised
- Sheba Medical Center1
- The Dalia and David Arabov Endocrinology and Diabetes Research Center1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Acetosulfame in the shared literature.
2 shared diseases1 shared paper
References & data sources
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature